| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8969317 | Vaccine | 2005 | 5 Pages |
Abstract
Although the formulations with 2.5 and 1.25 μg of CRM197-Hib elicited lower levels of anti-PRP GMTs, they were immunogenic and are possible candidates for further development.
Keywords
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Eda Tamm, Alessandra Veronese, Mario Contorni, Sirli Meriste, Pantaleo Nacci, Simonetta Viviani,